2002
DOI: 10.1210/jcem.87.6.8559
|View full text |Cite
|
Sign up to set email alerts
|

A Novel Nonstop Mutation in the Stop Codon and a Novel Missense Mutation in the Type II 3β-Hydroxysteroid Dehydrogenase (3β-HSD) Gene Causing, Respectively, Nonclassic and Classic 3β-HSD Deficiency Congenital Adrenal Hyperplasia

Abstract: We investigated two novel point mutations in the human type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing a mild and a severe form of 3beta-HSD deficiency congenital adrenal hyperplasia. The first is a nonstop mutation in the normal stop codon 373 of the gene in exon IV [TGA (Stop) --> TGC (Cys) = Stop373C) identified from one allele of a female child with premature pubarche whose second allele had an E142K mutation. The Stop373C mutation predictably results in an open reading frame and a muta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
19
0

Year Published

2004
2004
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(20 citation statements)
references
References 23 publications
1
19
0
Order By: Relevance
“…Treatment resulted in testicular growth and pubertal advancement, but effect on gynecomastia was not further described. In HSD3B2 deficiency, development of secondary sexual characteristics and marked gynecomastia at puberty has been described in 46,XY DSD individuals and seems not to correlate with the severity of enzyme deficiency (Table 3) (2,5,6,7,8,9,10,11,12,13,14,19,20,22). Gynecomastia may rather correspond to peripheral precursor conversion to estrogens which depends on accuracy of replacement therapy and peripheral HSD3B1 activity.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Treatment resulted in testicular growth and pubertal advancement, but effect on gynecomastia was not further described. In HSD3B2 deficiency, development of secondary sexual characteristics and marked gynecomastia at puberty has been described in 46,XY DSD individuals and seems not to correlate with the severity of enzyme deficiency (Table 3) (2,5,6,7,8,9,10,11,12,13,14,19,20,22). Gynecomastia may rather correspond to peripheral precursor conversion to estrogens which depends on accuracy of replacement therapy and peripheral HSD3B1 activity.…”
Section: Discussionmentioning
confidence: 99%
“…Case Report M-A Burckhardt and others Histology of HSD3B2 deficiency 173:5 K6 described pubertal development (Table 3) (2,5,6,7,8,9,10,11,12,13,14,19,20). Remarkably, the adrenal phenotype was mostly more severe than the DSD phenotype, and all subjects spontaneously virilized at puberty (when not gonadectomized).…”
Section: European Journal Of Endocrinologymentioning
confidence: 98%
“…A different mutation was also described in the same position at the protein, the p.P222T, and was associated with premature pubarche, but not salt-wasting form. Notably, the mutated protein 222T was not detected on in vitro assays with transiently transfected 293 cells, bringing up an additional pathogenic mechanism of a severe impairment in protein stability (32).…”
Section: Discussionmentioning
confidence: 97%
“…At birth, she was misdiagnosed as having 21-hydroxylase deficiency CAH, based on elevated 17-OHP and testosterone levels, and the correct diagnosis was carried out at 7 years of age. A nonstop mutation in the stop codon 373 (Stop373C), was identified in a female child with late-onset CAH [25]: the Stop373C leads to an open reading frame of 95 additional amino acid residues, resulting in a mutant enzyme with 467 amino acid residues compared to the 372 amino acid residues of the normal protein. The authors suggest that this extra tail of the enzyme produces an unstable protein, so that the protein is made but quickly falls apart.…”
Section: Discussionmentioning
confidence: 99%